Serum levels of vitamin C and vitamin D in a cohort of critically ill COVID-19 patients of a north American community hospital intensive care unit in may 2020. A pilot study
The COVID-19 pandemic has placed an enormous and growing burden on the population and health infrastructure, warranting innovative ways to mitigate risk of contracting and developing severe forms of this disease. A growing body of literature raises the issue of Vitamin C and Vitamin D as a risk-asse...
- Autores:
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/13548
- Acceso en línea:
- https://www.sciencedirect.com/science/article/pii/S2590098620300518?via%3Dihub#ab0005
http://hdl.handle.net/20.500.12010/13548
https://doi.org/10.1016/j.medidd.2020.100064
- Palabra clave:
- Critical illness
Intensive care unit (ICU)
Serum vitamin C
Serum vitamin D
Age
Body mass index (BMI)
HbA1c (glycated hemoglobin)
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
- Rights
- License
- Acceso restringido
| Summary: | The COVID-19 pandemic has placed an enormous and growing burden on the population and health infrastructure, warranting innovative ways to mitigate risk of contracting and developing severe forms of this disease. A growing body of literature raises the issue of Vitamin C and Vitamin D as a risk-assessment tool, and therapeutic option, in COVID-19. |
|---|